Showing 10,421 - 10,440 results of 44,157 for search '(( 5 ((teer decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.10s Refine Results
  1. 10421

    Targeting Acidic Mammalian chitinase Is Effective in Animal Model of Asthma by Marzena Mazur (4761027)

    Published 2017
    “…Rational design, guided by X-ray analysis of several inhibitors bound to human chitotriosidase (hCHIT1), led to the identification of compound <b>7f</b> as a highly potent AMCase inhibitor (IC<sub>50</sub> values of 14 and 19 nM against human and mouse enzyme, respectively) and selective (>150× against mCHIT1) with very good PK properties. …”
  2. 10422
  3. 10423
  4. 10424
  5. 10425

    Withaferin-A Reduces Type I Collagen Expression In Vitro and Inhibits Development of Myocardial Fibrosis In Vivo by Azariyas A. Challa (143195)

    Published 2012
    “…In mice, administration of 4 mg/kg WF-A daily for 2 weeks reduced isoproterenol-induced myocardial fibrosis by 50%. …”
  6. 10426

    Mean (top panel) and percentile rank (bottom panel) regression estimates of brain tissue volume across age in the AD sample (n=219). by David Alexander Dickie (499804)

    Published 2013
    “…<p>The slopes of these lines represent the beta coefficients in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0084093#pone-0084093-t005" target="_blank">table 5</a>. The mean-based model expects all percentile ranks to change at the same rate, i.e. be parallel. …”
  7. 10427
  8. 10428
  9. 10429
  10. 10430
  11. 10431

    Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation by Nabil G. Seidah (148050)

    Published 2012
    “…Western blotting and immunohistochemistry of <em>AnxA2<sup>−/−</sup></em> tissues revealed that the LDLR was decreased by ∼50% in extrahepatic tissues, such as adrenals and colon. …”
  12. 10432

    S2 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  13. 10433

    S1 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  14. 10434
  15. 10435

    DAT and NAT activity and the effects of MPP(+) on mitochondrial activity in SH-SY5Y cells. by Joanna A. Korecka (415952)

    Published 2013
    “…Mitochondrial intensity is significantly increased in RA treated SH-SY5Y cells treated with 0.01 mM MPP(+) up to 0.05 mM, and significantly decreased in cells treated with 0.1 mM, 0.05 mM and 1 mM MPP(+). …”
  16. 10436
  17. 10437
  18. 10438

    Quantitative determination of loss of MMP in SH-SY5Y cells in response to Grx1 knockdown. by Uzma Saeed (49670)

    Published 2008
    “…<p>Grx1 was downregulated in SH-SY5Y cells using shRNA. Cells were treated with vehicle after transfecting them with empty vector, or with vehicle, α-lipoic acid (100 µM) or cyclosporine A (10 µM), 6 hr post transfection with shRNA to Grx1 and MMP was measured using TMRM as the indicator dye. …”
  19. 10439
  20. 10440

    Supplementary Material for: Association of Four Genetic Loci with Uric Acid Levels and Reduced Renal Function: The J-SHIPP Suita Study by Tabara Y. (4123405)

    Published 2010
    “…<i>Results:</i> Serum UA levels were significantly different between the SLC22A12 rs11231825 (CC/CT/TT: 4.5 ± 1.6, 5.0 ± 1.4, 5.3 ± 1.4 mg/dl; p = 7.6 × 10<sup>–20</sup>), SLC2A9 rs1014290 (TT/TG/GG: 4.9 ± 1.4, 5.1 ± 1.4, 5.3 ± 1.4 mg/dl; p = 3.1 × 10<sup>–11</sup>) and ABCG2 rs2231142 (TT/TG/GG: 5.3 ± 1.5, 5.2 ± 1.4, 5.1 ± 1.4 mg/dl; p = 2.0 × 10<sup>–5</sup>) genotypes. …”